Vertex Pharmaceuticals Inc MA (VRTX) Form 4 Filed by Kristen Ambrose, Feb 28, 2025
SEC Form 4 · No Market Transaction
Tax Withholding
Shares withheld for tax obligations.
Equity Position
7.85K sh
9,086 → 7,845
Equity Change
-13.7%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Kristen Ambrose CIK 0001856587 |
CAO
|
Kristen Ambrose at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,978,865
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-09-01 | Award | — | View |
| 2026-03-02 | Sell | -$172,560 | View |
| 2026-02-26 | Sell | -$108,456 | View |
| 2026-02-19 | Sell | -$1,064,297 | View |
| 2026-02-18 | - | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2025-02-26 | F - Tax Payment | 1,241 D | $479.61 | -$595,196 | 7,845 | Direct |
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000875320-25-000122
API docs
View Original SEC Filing